Coronary Stents Prices Slashed by 85%: Gov’t Tells High Court The prices of life-saving coronary stents, used in angioplasty to ensure blood supply to and from the heart, have been slashed by 85 percent from their existing prices and capped, government said, March 2. – @Siliconeer #Siliconeer #India #Healthcare #SouthAsianHeart #Stents @NaMo #NaMo @Narendramodi #NarendraModi    The price of drug eluting stents http://siliconeer.com/current/coronary-stents-prices-slashed-b

Coronary Stents Prices Slashed by 85%: Gov’t Tells High Court The prices of life-saving coronary stents, used in angioplasty to ensure blood supply to and from the heart, have been slashed by 85 percent from their existing prices and capped, government said, March 2. – @Siliconeer #Siliconeer #India #Healthcare #SouthAsianHeart #Stents @NaMo #NaMo @Narendramodi #NarendraModi The price of drug eluting stents http://siliconeer.com/current/coronary-stents-prices-slashed-b

Dual Antiplatelet Therapy Following Coronary Stent Implantation Associated With Significant Improvement

Dual Antiplatelet Therapy Following Coronary Stent Implantation Associated With Significant Improvement

FDA Approval of the Zilver PTX Drug-Eluting Stent: An Interview with Gary M. Ansel, MD | Vascular Disease Management

FDA Approval of the Zilver PTX Drug-Eluting Stent: An Interview with Gary M. Ansel, MD | Vascular Disease Management

We're the first Medical Center in Southern California to offer the Zilver® PTX® Drug Eluting Stent designed to treat peripheral artery disease and prevent the re-narrowing of the femoral artery.

We're the first Medical Center in Southern California to offer the Zilver® PTX® Drug Eluting Stent designed to treat peripheral artery disease and prevent the re-narrowing of the femoral artery.

Cook Medical is First to Win FDA Approval of Drug-Eluting Stent     11/16/2012 8:23:44 AM    Cook Medical has received FDA approval for the first drug-eluting stent to treat peripheral artery disease in the U.S. The Zilver PTX Drug-Eluting Peripheral Stent is a self-expanding metal stent coated with the drug paclitaxel to help prevent recurring narrowing of the artery. Drug-eluting stents are currently approved for use in coronary arteries in heart attack patients.

Cook Medical is First to Win FDA Approval of Drug-Eluting Stent 11/16/2012 8:23:44 AM Cook Medical has received FDA approval for the first drug-eluting stent to treat peripheral artery disease in the U.S. The Zilver PTX Drug-Eluting Peripheral Stent is a self-expanding metal stent coated with the drug paclitaxel to help prevent recurring narrowing of the artery. Drug-eluting stents are currently approved for use in coronary arteries in heart attack patients.

The most common involvement occurs in the superficial femoral artery where most of the diseases are occlusion disease, with long occlusions where you require mostly by either stent or drug-eluting balloon. At the present movement drug eluting stent is found to be equivalent or better than that of the plain stent but newer plain stents like superior stent is equivalent to that of the drug eluting stent. .

The most common involvement occurs in the superficial femoral artery where most of the diseases are occlusion disease, with long occlusions where you require mostly by either stent or drug-eluting balloon. At the present movement drug eluting stent is found to be equivalent or better than that of the plain stent but newer plain stents like superior stent is equivalent to that of the drug eluting stent. .

Free Preview for Drug-Eluting Coronary-Artery Stents

Free Preview for Drug-Eluting Coronary-Artery Stents

Pinterest
Search